Tumor-infiltrating B cells are heterogeneous, and their roles in tumor immunity are controversial. In this issue of Cell, Lu and colleagues demonstrate that chemotherapy-induced complement signals promote the generation of ICOSL+B cells, which enhance tumor-specific T cell responses.
|Original language||English (US)|
|Number of pages||3|
|State||Published - Mar 19 2020|
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)